// App-Quantinova.ai

365 : Mobilizing prostate cancer cells from the endosteal niche by targeting the SDF-1/CXCR4 axis

Researchers

Presenter

  • Kenneth C. Valkenburg

Principal Investigators

  • Kenneth J. Pienta

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • C-X-C motif chemokine receptor 4

  • Granulocyte colony-stimulating factor

  • Stromal cell-derived factor 1

Drug/Treatment

  • Filgrastim

  • Plerixafor

  • Docetaxel

  • AMD-3100

  • CXCL12

  • SDF-1

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved